Literature DB >> 34011604

Anxiety and depression levels of the general population during the rapid progressing stage in the coronavirus disease 2019 outbreak: a cross-sectional online investigation in China.

Zeya Shi1, Yuelan Qin1, Sek Ying Chair2, Yanhui Liu3, Yu Tian4, Xin Li1, Wanqin Hu1, Qun Wang5.   

Abstract

OBJECTIVE: The outbreak of COVID-19 has major impacts on the psychological health of the public. This study aimed to investigate the anxiety and depression levels of the general population during the rapid progressing stage of COVID-19 pandemic in China and to explore the associated factors. DESIGN AND
SETTING: A cross-sectional online survey. PARTICIPANTS: 2651 Chinese people. MEASURES: The Hospital Anxiety and Depression Scale was used to measure their psychological health. A structured questionnaire collected possible associated factors, including sociodemographic characteristics, health information, contact history-related information, experience and perceptions, knowledge and education and adopted precautions. Multiple linear regression was conducted to explore the factors associated with anxiety and depression.
RESULTS: The mean score of anxiety and depression was 4.35 and 4.38, respectively. The rates of people with anxiety and depressive symptoms (with >7 score in the subscale) were 14.15% and 17.35%, respectively. Participants without political party membership, with contact history of COVID-19, going out or gathering, taking Chinese medicine herbs, being unsatisfied with current precautions, perceiving higher risks of infection, lower knowledge and poorer health presented higher anxiety and depression levels. Moreover, those who were females, married, lived alone and wore mask were more anxious; whereas people who were younger, experienced public health crisis, did not take precautions (regular work-rest, exercise) had higher depression level.
CONCLUSIONS: During the rapid progressing stage of COVID-19 pandemic in China, one-seventh and one-sixth respondents presented anxiety and depression symptoms, respectively. The risk factors for anxiety and depression included the following: without political party membership, with contact history of COVID-19, going out or gathering, wearing masks, taking Chinese medicine herbs, being unsatisfied with current precautions, perceiving higher susceptibility, lower knowledge and poorer health status. Extensive information and psychological support should be provided to improve the mental health of the general population. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COVID-19; anxiety disorders; depression & mood disorders

Year:  2021        PMID: 34011604     DOI: 10.1136/bmjopen-2021-050084

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  4 in total

1.  Use of Traditional, Complementary and Integrative Medicine During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.

Authors:  Tae-Hun Kim; Jung Won Kang; Sae-Rom Jeon; Lin Ang; Hye Won Lee; Myeong Soo Lee
Journal:  Front Med (Lausanne)       Date:  2022-05-09

2.  A year with the fear of COVID-19 in multiple sclerosis patients: Examination of depression, sleep quality and quality of life before and after the pandemic.

Authors:  Kubra Yeni; Zeliha Tulek; Murat Terzi
Journal:  Mult Scler Relat Disord       Date:  2021-11-10       Impact factor: 4.339

Review 3.  Prevalence of anxiety during the COVID-19 pandemic: A systematic review and meta-analysis of over 2 million people.

Authors:  Felipe Mendes Delpino; Carine Nascimento da Silva; Jeferson Santos Jerônimo; Eliete Stark Mulling; Larissa Leal da Cunha; Marina Krause Weymar; Ricardo Alt; Eduardo L Caputo; Natan Feter
Journal:  J Affect Disord       Date:  2022-09-10       Impact factor: 6.533

4.  Analysis of Anxiety and Depression Status in Patients Undergoing Radiotherapy During the COVID-19 Epidemic.

Authors:  Liping Yang; Jing Yang; Jian He; Yan Zhou; Yangyang Zhang; Bin Sun; Jing Gao; Liting Qian
Journal:  Front Psychiatry       Date:  2021-12-10       Impact factor: 5.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.